Evergreen Corporation
EVGR
Other OTC11.95
USD
+11.95
- -
CIK
0001900402
ISIN
KYG3312W1096
CUSIP
G3312W109
Return %
Stock
S&P500
1Y
-3.71
18.21
3Y
13.81
64.38
5Y
20.34
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Choon Lian Liew
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 15-04, The Pinnacle Petaling Jaya Malaysia 47810
- IPO Date
- Apr 5, 2022
- CIK
- 0001900402
- Similar Companies
- Business
- Evergreen Corporation (EVGR) operates as a blank check company, or special purpose acquisition company (SPAC), focused on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, particularly in the technology sector with large addressable markets, significant revenue growth, and strong technological capabilities. Incorporated in 2021 and headquartered at Glo Damansara, 699 Kuala Lumpur, 60000 Malaysia, the Cayman Islands-domiciled company currently has no significant operations and maintains its cash in trust pending a suitable target. Choon Lian Liew serves as chief executive officer and chairman, with Izmet Iskandar Bin Mohd Ramli as chief financial officer and director. In September 2024, Evergreen Corporation entered into a definitive business combination agreement to merge with Forekast Limited, a provider of technology managed services and augmented intelligence solutions for midsize and large enterprises aimed at improving decision-making, operational efficiency, and customer experiences; post-merger, the combined entity will operate as Forekast Group with an implied enterprise value for Forekast of $105 million, subject to customary closing conditions including SEC registration effectiveness and shareholder approvals, with completion anticipated by year-end 2024. Funds remaining in Evergreen's trust after redemptions will support Forekast's research and development, marketing expansion, market entry, talent acquisition, and potential strategic acquisitions. The transaction aligns with Evergreen's focus on high-growth technology opportunities amid AI-driven industry transformation.